Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-12-02, Stock:JNJ, The news for the past five days is as follows:
2020-11-24: NEWS1: Merck Sales Hit Hardest by Pandemic.NEWS2: Moderna Set to Sell 160 Million Coronavirus Vaccine Doses to EU.NEWS3: 'Reflationary trends' are going to continue into 2021: Research Affiliates.NEWS4: EU strikes deal with Moderna to supply up to 160 million COVID vaccine shots.NEWS5: Pennant Investors Exits Johnson & Johnson, Cuts Amazon.NEWS6: How Does AstraZeneca's COVID-19 Vaccine Data Compare to Others'?.NEWS7: Coronavirus vaccine: AstraZeneca could expand US trial to pursue 90% efficacious vaccine.
2020-11-25: NEWS1: Overlook Novavax at the Risk of Incurring an Opportunity Cost.NEWS2: COVID-19 is the ‘silent pandemic’, this surge is not like last spring: Robert Redfield.NEWS3: 3 Stocks to Help You Build Retirement Wealth.NEWS4: What Does Johnson & Johnson's Debt Look Like?.
2020-11-27: NEWS1: Peru secures 23.1 million future coronavirus vaccine doses from Pfizer, COVAX.NEWS2: Stock market news live updates: Wall Street notches slim gains; Nasdaq, S&P 500 set new records.NEWS3: Here's How Much Investing $1,000 In Major Coronavirus Vaccine Developers Before Their Announcements Would Fetch.NEWS4: Should iShares Russell Top 200 Value ETF (IWX) Be on Your Investing Radar?.
2020-11-30: NEWS1: U.S. coronavirus cases pass 4 million in the month of November.NEWS2: Is Johnson & Johnson (JNJ) A Good Stock To Buy?.
2020-12-01: NEWS1: Activist Shareholders Press Pfizer, J&J, and Other Pharma Companies on Covid Vaccine Price and Access.NEWS2: Want to Invest in Coronavirus Vaccines? Consider This First.NEWS3: New Advances in Treating Difficult Blood Cancers From Johnson & Johnson and Others.NEWS4: I’ve already been injected with a COVID vaccine. This is why I’m cheering for the Novavax underdog.NEWS5: Cramer Weighs In On Peloton, Johnson & Johnson And More.NEWS6: Moderna (MRNA) Seeks Nod for Emergency Use of COVID-19 Vaccine.NEWS7: AstraZeneca (AZN) Forxiga Approved in Japan for Heart Failure.NEWS8: New Survey Finds Critical Need for Education on Cataracts and Modern Treatment Options.NEWS9: Here's Why Johnson & Johnson Is Still in the Coronavirus Vaccine Race.

Answer: Rise